Rapid effector function of circulating NC16A-specific T cells in individuals with mucous membrane pemphigoid

被引:15
作者
Black, APB
Seneviratne, SL
Jones, L
King, AS
Winsey, S
Arsecularatne, G
Wojnarowska, F
Ogg, GS [1 ]
机构
[1] Weatherall Inst Mol Med, Immunol Grp, Oxford OX3 9DS, England
[2] Churchill Hosp, Dept Dermatol, Oxford OX3 7LJ, England
基金
英国医学研究理事会;
关键词
BP180; mucous membrane pemphigoid; NC16A; T cells;
D O I
10.1111/j.1365-2133.2004.06219.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Mucous membrane pemphigoid (MMP) is a chronic blistering skin disease frequently associated with circulating autoantibodies directed to a number of antigens including the NC16A region of BP180. NC16A domain-specific T cells have been identified in the blood of individuals with bullous pemphigoid (BP), pemphigoid gestationis and linear IgA disease, but there are no data investigating the potential role for such T cells in the pathogenesis of MMP. Objectives To test the hypothesis that NC16A-specific T cells exist in the peripheral blood of individuals with MMP. Methods We isolated peripheral blood mononuclear cells from 10 patients with MMP, 17 with BP and 10 healthy controls and examined the immunogenicity of overlapping peptides spanning the NC16A domain using interferon (IFN)-gamma enzyme-linked immunospot assay. Results Significant IFN-gamma production was observed in response to the NC16A peptides in two of the patients with MMP and two of the patients with BP but in none of the normal controls. These data suggest that in a minority of individuals with MMP, NC16A domain-specific T cells circulate at sufficiently high frequency to be detectable directly ex vivo and to show rapid effector function. Conclusions Overall, these findings are the first to examine the potential role for antigen-specific autoreactive T cells in the pathogenesis of MMP, and confirm that in some individuals the NC16A domain may be an important target antigen.
引用
收藏
页码:1160 / 1164
页数:5
相关论文
共 23 条
[1]   Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain [J].
Balding, SD ;
Prost, C ;
Diaz, LA ;
Bernard, P ;
Bedane, C ;
Aberdam, D ;
Giudice, GJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (01) :141-146
[2]   CYTOKINES IN THE CONJUNCTIVA OF ACUTE AND CHRONIC MUCOUS-MEMBRANE PEMPHIGOID - AN IMMUNOHISTOCHEMICAL ANALYSIS [J].
BERNAUER, W ;
WRIGHT, P ;
DART, JK ;
LEONARD, JN ;
LIGHTMAN, S .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1993, 231 (10) :563-570
[3]  
BERNAUER W, 1993, OPHTHALMOLOGY, V100, P339
[4]   Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls [J].
Büdinger, L ;
Borradori, L ;
Yee, C ;
Eming, R ;
Ferencik, S ;
Grosse-Wilde, H ;
Merk, HF ;
Yancey, K ;
Hertl, M .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (12) :2082-2089
[5]   Cytokine profile and supposed contribution to scarring in cicatricial pemphigoid [J].
Caproni, M ;
Calzolari, A ;
Salvatore, E ;
Giomi, B ;
Volpi, W ;
D'Agata, A ;
Santucci, M ;
Fabbri, P .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2003, 32 (01) :34-40
[6]   IL-4, IL-5, TGF-β1 and IFN-γ mRNAs detected by a new in situ amplification system in cicatricial pemphigoid [J].
Caproni, M ;
Calzolari, A ;
Giomi, B ;
Santucci, M ;
Ficarra, G ;
Fabbri, P .
EXPERIMENTAL DERMATOLOGY, 2002, 11 (05) :421-427
[7]   THE IMMUNOLOGICAL FEATURES AND PATHOPHYSIOLOGY OF OCULAR CICATRICIAL PEMPHIGOID [J].
ELDER, MJ ;
LIGHTMAN, S .
EYE, 1994, 8 :196-199
[8]   Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay [J].
Eming, R ;
Büdinger, L ;
Riechers, R ;
Christensen, O ;
Bohlen, H ;
Kalish, R ;
Hertl, M .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (06) :1279-1282
[9]  
GIUDICE GJ, 1993, J IMMUNOL, V151, P5742
[10]  
LABIB RS, 1986, J IMMUNOL, V136, P1231